Current and historical daily PE Ratio for Biotest AG (
) from 1990 to Jun 22 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Biotest AG stock (FRA:BIO) PE ratio as of Jun 22 2024 is 7.95.
More Details
Biotest AG (FRA:BIO) PE Ratio (TTM) Chart
Biotest AG (FRA:BIO) PE Ratio (TTM) Historical Data
View and export this data going back to 1990. Start your Free Trial
Total 1266
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| Biotest AG PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-22 | 7.9 | 2024-04-19 | 8.0 |
| 2024-06-21 | 7.9 | 2024-04-18 | 8.0 |
| 2024-06-20 | 7.9 | 2024-04-17 | 8.0 |
| 2024-06-19 | 7.9 | 2024-04-16 | 8.1 |
| 2024-06-18 | 7.9 | 2024-04-15 | 8.0 |
| 2024-06-17 | 7.9 | 2024-04-12 | 8.0 |
| 2024-06-14 | 7.8 | 2024-04-11 | 8.2 |
| 2024-06-13 | 7.8 | 2024-04-10 | 8.0 |
| 2024-06-12 | 7.8 | 2024-04-09 | 8.0 |
| 2024-06-11 | 7.9 | 2024-04-08 | 8.0 |
| 2024-06-10 | 7.8 | 2024-04-05 | 8.1 |
| 2024-06-07 | 7.9 | 2024-04-04 | 8.2 |
| 2024-06-06 | 7.9 | 2024-04-03 | 8.0 |
| 2024-06-05 | 8.0 | 2024-04-02 | 8.1 |
| 2024-06-04 | 7.9 | 2024-03-28 | 8.2 |
| 2024-06-03 | 8.0 | 2024-03-27 | 10.9 |
| 2024-05-31 | 7.9 | 2024-03-26 | 10.8 |
| 2024-05-30 | 8.0 | 2024-03-25 | 10.8 |
| 2024-05-29 | 8.0 | 2024-03-22 | 10.8 |
| 2024-05-28 | 8.0 | 2024-03-21 | 10.8 |
| 2024-05-27 | 8.0 | 2024-03-20 | 10.8 |
| 2024-05-24 | 7.9 | 2024-03-19 | 10.9 |
| 2024-05-23 | 7.9 | 2024-03-18 | 10.6 |
| 2024-05-22 | 8.0 | 2024-03-15 | 10.7 |
| 2024-05-21 | 8.0 | 2024-03-14 | 10.4 |
| 2024-05-20 | 8.0 | 2024-03-13 | 10.7 |
| 2024-05-17 | 8.0 | 2024-03-12 | 10.7 |
| 2024-05-16 | 8.0 | 2024-03-11 | 10.7 |
| 2024-05-15 | 8.0 | 2024-03-08 | 10.7 |
| 2024-05-14 | 8.0 | 2024-03-07 | 10.7 |
| 2024-05-13 | 8.0 | 2024-03-06 | 10.7 |
| 2024-05-10 | 8.0 | 2024-03-05 | 10.7 |
| 2024-05-09 | 8.0 | 2024-03-04 | 10.7 |
| 2024-05-08 | 8.0 | 2024-03-01 | 10.8 |
| 2024-05-07 | 7.9 | 2024-02-29 | 10.7 |
| 2024-05-06 | 8.0 | 2024-02-28 | 10.8 |
| 2024-05-03 | 8.0 | 2024-02-27 | 10.8 |
| 2024-05-02 | 8.0 | 2024-02-26 | 10.7 |
| 2024-04-30 | 8.0 | 2024-02-23 | 10.7 |
| 2024-04-29 | 8.0 | 2024-02-22 | 10.7 |
| 2024-04-26 | 8.0 | 2024-02-21 | 10.7 |
| 2024-04-25 | 8.0 | 2024-02-20 | 10.7 |
| 2024-04-24 | 8.0 | 2024-02-19 | 10.7 |
| 2024-04-23 | 8.0 | 2024-02-16 | 10.7 |
| 2024-04-22 | 8.0 | 2024-02-15 | 10.7 |
Biotest AG (FRA:BIO) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Biotest AG
NAICS : 325412
ISIN : DE0005227201
Share Class Description:
FRA:BIO: Ordinary SharesCompare
Compare
Traded in other countries / regions
BIO3.Germany0N70.UKBIO3.AustriaBIO3.SwitzerlandBIESF.USA IPO Date
1987-10-14Description
Biotest AG is a supplier of biological medicines. The company produces its products from human blood plasma or manufactured by using biotechnology methods. It is engaged in the area of hematology, clinical immunology, and intensive care medicine. The operating business segments are Therapy, Plasma and Services, and Other segments. It generates maximum revenue from the Therapy segment. Geographically, it derives a majority of revenue from Central Europe and also has a presence in other countries.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers